Clinical Trials Browser

Phase 2 × Recurrence × pegaspargase × Clear all

NCT02535806 2019-08-13

Four Drug Reinduction With Bortezomib for Relapsed or Refractory ALL or LL in Children and Young Adults

Phase 2 Terminated

2 enrolled 11 charts

LymphoidOther hematologic neoplasm

Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01313078 2015-10-09

Phase II Study of Clinical Activity of Pegaspargase in Women With Relapsed or Refractory Epithelial Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer

Phase 2 Completed

4 enrolled 9 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms, Recurrence